![]() |
|||||
Dear desirae, I have important news to share with you. Yesterday, we learned that an Indian court dismissed the suit brought by pharmaceutical company Novartis that could have greatly reduced the supply of affordable, lifesaving medications for the world's poor. In addition, Novartis says it is unlikely to appeal the ruling! In 2006, Novartis brought a suit against the Indian government to change a section of the country's patent law that safeguards public health. If Novartis had won the case, the production of Indian generic drugs could have been cut back -- and millions of people around the world could have lost access to the medicine they need. More than 45,000 CARE
supporters responded by sending letters urging Novartis CEO Dr.
Vasella to drop the case and protect affordable lifesaving
medicines for the developing world. Although Novartis did
not drop its case, after weeks of intense public pressure, it
announced that it is unlikely to appeal the Indian court's
ruling. This is outstanding news -- for those of us
working to defend the right to health and for millions of people
who are living productive lives thanks to Indian generic
drugs. Click here to read the press
release from CARE.
I wanted to share with you just
a few quotes from letters to Novartis sent by CARE
supporters:
"I hope you know what AIDS has done and
is still doing in -- Yesterday's news illustrates
the enormous impact we can achieve with the help of CARE
supporters like you. Thank you for all you do to empower
women and families around the world to live healthy, productive
and happy lives.
Sincerely, Helene D. Gayle MD, MPH President and CEO, CARE | |||||
|
If you would like to update your personal contact information or unsubscribe from CARE's e-mail list, please click here to access your personal profile page. You can manage the types of e-mail you receive from CARE by clicking here. Click here for Federal and State compliance notices. CARE is a leading humanitarian organization fighting root causes of poverty. Our U.S. headquarters are at 151 Ellis Street NE, Atlanta GA, 30303-2420. | |||||